MacManus, Michael P
Akhurst, Tim
Lewin, Sharon R
Hegi-Johnson, Fiona
Funding for this research was provided by:
AstraZeneca Australia (NA)
Article History
Received: 15 October 2023
Accepted: 16 February 2024
First Online: 7 June 2024
Declarations
:
: This report includes 5 patients who were entered on a phase 0 clinical trial that was approved by the human research and ethics committee of the Peter MacCallum Cancer Centre. The trial was registered with the Australian and New Zealand Clinical Trials Registry (Number 12,621,000,171,819). This trial was approved by the hospital ethics committee and all patients gave informed consent.
: All patients gave consent to publication as part of the ethics process.
: This report includes findings from an investigator initiated clinical trial that was funded by Astra Zeneca. Fiona Hegi-Johnson has received speakers fees from Astra Zeneca.